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Protective Role of CD40 in Leishmania major
Infection at Two Distinct Phases of
Cell-Mediated Immunity
Masahito Kamanaka,* Philipp Yu,* CD40±CD40L interaction also plays a critical role in cell-
mediated immune responses.Teruhito Yasui,* Kenji Yoshida,*
Tsutomu Kawabe,* Toshihiro Horii,² Experimental infection with the intracellular proto-
zoan, Leishmania major, is an excellent model to studyTadamitsu Kishimoto,³ and Hitoshi Kikutani*
*Institute for Molecular and Cellular Biology cell-mediated host defense mechanisms (Liew and
O'Donnell, 1993; MuÈ ller et al., 1989; Reiner and Locksley,²Research Institute for Microbial Diseases
Osaka University 1995). The severity of disease in mice infected with L.
major is genetically determined. In the resistant strains³Department of Medicine III
Osaka University Medical School such as C57BL/6 and CBA, Th1 effector T cells are
generated upon infection, whereas Th2 responses areSuita, Osaka 565
Japan preferentially generated in the susceptible strain,
BALB/c (Heinzel et al., 1989, 1991; Boom et al., 1990).
It has been shown that Th1-derived interferon-g (IFNg)
and Th2-derived interleukin-4 (IL-4) play a role in protec-Summary
tion from and exacerbation of experimental leishmania-
sis, respectively (Sadick et al., 1990; Belosevic et al.,CD40-deficient mice are susceptible to Leishmania
1989). Experimental leishmaniasis cannot be controlledmajor infection while their wild-type littermates can
in IFNg-deficient mice (Wang et al., 1994). However,resolve the infection. Upon stimulation with L. major
IFNg is necessary but not sufficient for activation ofantigens, draining lymph node T cells of the mutant
macrophages to a leishmanicidal state, since adminis-mice and the susceptible mice, BALB/c, secrete com-
tration of IFNg or infection with transfected L. majorparable amounts of IL-4. The mutant mice produce
expressing IFNg failed to convert a nonhealer to a healerless IFNg than wild-type mice. The expression of IL-12
strain (Tobin et al., 1993). Another important cytokine inp40 mRNA was significantly lower in L. major antigen-
the control of L. major infection is IL-12, which is knownstimulated cells of mutant mice than those of wild-
to promote the generation of IFNg-producing Th1 ef-type or BALB/c mice. In normal mice, engagement of
fector cells. In vivo IL-12 treatment can cure BALB/cCD40 activates macrophages to a leishmanicidal state
mice of L. major infection by changing a Th2 responsein vitro in the presence of IFNg. The results suggest
to a Th1 response (Heinzel et al., 1993; Sypek et al.,that the CD40±CD40 ligand interaction plays an impor-
1993). It still remains to be answered what kind of mech-tant role in two criticalsteps of cell-mediated immunity
anisms are involved in production of IL-12 and genera-to L. major infection: the generation of a Th1 response
tion of Th1 responses to L. major and which moleculesand activation of macrophages to a leishmanicidal
other than IFNg are required for activation of macro-state.
phages. One attractive hypothesis is that costimulatory
molecules such as CD40 may contribute to the regula-Introduction
tion of protective Th1 responses as well as macrophage
activation.The interaction between CD40 on B cells and CD40
To study the effect of the CD40±CD40L interaction inligand (CD40L) on activated T cells is known tobe essen-
cell-mediated immunity, we have investigated the im-tial for the establishment of effective humoral immune
mune responses of CD40-deficient mice to L. major. Ourresponses (Banchereau et al., 1994). This has been
data show that the CD40±CD40L interaction is essentialclearly demonstrated by the defect of immunoglobulin
for the control of L. major infection.class switching and germinal center formation in pa-
tients with hyper immunoglobulin M (IgM) syndrome car-
rying mutations in the CD40L gene (Allen et al., 1993; Results
Aruffo et al., 1993; DiSanto et al., 1993; KorthaÈ uer et al.,
1993) and in mice deficient for CD40L (Renshaw et al., CD40-Deficient Mice Are Susceptible
to Leishmania major Infection1994; Xu et al., 1994) or CD40 (Kawabe et al., 1994;
Castigli et al., 1994). CD40 is also expressed on profes- CD40-deficient mice, their wild-type (C57BL/6 3 129)F2
littermates, and BALB/c mice were infected by injectingsional antigen-presenting cells such as macrophages
and dendritic cells (Hart and McKenzie, 1988; Schriever their hind footpads with stationary phase L. major pro-
mastigotes. Initial footpad swelling was observed inet al., 1989). CD40 stimulation induces cytokine secre-
tion of macrophages in vitro (Alderson et al., 1993; both BALB/c and wild-type controls 3±8 weeks after
infection, as shown in Figure 1. The local lesions thenWagner et al., 1994). In vivo administration of anti-CD40L
suppresses experimentally induced autoimmune dis- healed in the wild-type mice while the disease continued
to progress in BALB/c mice. Interestingly, initial swellingeases and graft-versus-host reactions of mice (Durie et
al., 1993, 1994). Cryptosporidial diarrhea and Pneumo- was not observed in the CD40-deficient mice; however,
local lesions were detected later and continued to ex-cystis carinii pneumonia, which are characteristic op-
portunistic infections in T cell immunodeficiencies, are pand and progress (Figure 1). The development of leish-
maniasis in CD40-deficient mice was accompanied byoften observed in hyper IgM patients (Nortarangelo et
al., 1992). However, it remains unclear whether the increased numbers of parasites in spleens as well as
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that parasite-specific T cells may not emerge in the
absence of CD40 or that Th2 cells secreting IL-4 may
be preferentially generated in CD40-deficient mice, as
seen in susceptible BALB/c mice (Heinzel et al., 1989).
As shown in Figure 2, lymph node cells from CD40-
deficient and BALB/c mice produced significantly higher
levels of IL-4 in response to L. major antigens than
C57BL/6 or wild-type mice. Conversely, cells from resis-
tant, wild-type, and C57BL/6 mice produced high levels
of IFNg. In our hands, high levels of IFNg were also
detected in lymph node cultures from infected BALB/c
mice. Lymph node cells of themutant mice could secrete
only trace amounts of IFNg. This result suggests that
the CD40-deficient mice may be able to mount a Th2
response but not a Th1 response to L. major.
IL-12 mRNA Expression of Lymph NodeFigure 1. The Course of L. major Infection in CD40-Deficient Mice
Cells from Infected CD40-Deficient Mice
Groups of 6 CD40-deficient mice (open circle), 6 wild-type
It is possible that the defective interaction of CD40 onlittermates (closed circle), and 6 BALB/c (open square) mice were
macrophages with CD40L on Leishmania-reactive Tinfected by injecting hind footpads with 2 3 107 stationary phase
promastigotes of L. major and the course of disease monitored by cells may influence IL-12 production in infected mutant
weekly measurements of the local footpad lesion using a metric mice. To examine this hypothesis, we analyzed the abil-
caliper. Results are presented as differences in footpad thickness ity of lymph node cells from infected mutant mice to
between the infected and noninfected footpads. The values shown express IL-12 mRNA upon stimulation with L. major anti-
are means 6 SEM of 6 mice per each group. The results represent
gens. Lymph node cells from infected mutant, wild-type,three comparable experiments.
and BALB/c mice were cultured with L. major antigens
for 10 hr and then mRNA for p40, the inducible compo-
nent of IL-12 was quantitated by competitive reversedraining lymph nodes. As shown in Table 1, at the early
transcriptase polymerase chain reaction (RT±PCR). Asstage of infection similar or higher numbers of parasites
shown in Figure 3, lymph node cells from the mutantwere detected in draining lymph nodes of infected mu-
mice expressed significantly less IL-12 p40 mRNA thantant mice compared with those of BALB/c mice, al-
those of wild-type mice. Intermediate levels of IL-12though the footpad swelling of the mutant mice was
expression were observed in BALB/c mice. The resultmuch milder. The draining lymph nodes of BALB/c mice
suggests that the absence of CD40 on macrophagesbecame rapidly necrotic, while parasites continued to
may affect antigen-induced IL-12 production.increase in lymph nodes of mutant mice with much de-
layed necrotic destruction (data not shown). L. major
infection was also observed in spleens of the mutant
mice. These results indicate that the CD40-deficient CD40 Stimulation Induces Leishmanicidal
Activity in Macrophagesmice rather develop systemic leishmaniasis without se-
vere local lesions. The delayed onset of local footpad swelling and the
development of rather severe systemic disease in the
mutant mice may not be caused by the imbalance ofThe CD40-Deficient Mice Develop a Polarized
Th2 Response to L. major the TH1/TH2 phenotype and an impaired production of
IL-12 only. Hence, we studied the effect of CD40±CD40LThe first critical step of immune responses to L. major
is the induction of parasite-specific T cells. It is possible interaction on leishmanicidal activities of macrophages.
Table 1. Tissue Content of Leishmania major during Infection
Titer of viable Leishmania
Experiment number n Weeks Mouse type Spleena Lymph nodea
1 2 4 Wild type ND 285(347/223)b
2 4 CD402/2 ND 4166(6250/2083)b
2 4 BALB/c ND 1061(1388/735)b
2 3 25 Wild type ND 53 6 57
3 25 CD402/2 16348 6 16241 124206 6 164009
1 25 BALB/c ND Ðc
3 4 20 Wild type ND Not done
4 20 CD402/2 1899 6 880 Ðc
3 20 BALB/c 407 6 158 Ðc
ND, not detectable.
a Numbers of parasites from 0.4 g of spleen or 1 3 106 cells of draining lymph nodes.
b The numbers in parenthesis are parasite numbers from lymph node of individual mice.
c Impossible because of necrosis and bacterial infection.
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Figure 3. Quantification of IL-12 p40 mRNA Expression in the Drain-
ing Lymph Nodes of L. major-Infected Mice
Draining lymph node cells of 3 BALB/c, wild-type littermates
(C57BL/6 3 129)F2 and CD40-deficient mice (CD40 knockout) were
taken 21 days after infection, cultured for 10 hr with L. major antigen.
RNA expression for IL-12 and b2m as a standard for equal amounts
of cDNA was quantitated by RT±PCR using an internal competitor
fragment. Data are expressed as IL-12 molecules per PCR reaction
standardized to 6.3 3 105 b2m molecules per PCR reaction. (TheFigure 2. In Vitro Production of IL-4 and IFNg by Draining Lymph
means 6 SEM of data from 3 mice per each group are shown.) In
Node Cells of Infected Mice
the upper part for each group of mice, a representative PCR for IL-
Groups of 3±4 BALB/c, C57BL/6, CD40-deficient mice (CD40[2/2]) 12 and b2m at the identical dilution of the competitor plasmid is
and wild-type mice were infected to the footpads. Cells of draining shown. For b2m the same band intensity between plasmid competi-
lymph nodes were stimulated 6 weeks after infection with freeze± tor and cDNA indicates equal amounts of cDNA. The different IL-
thawed promastigote antigens. The culture supernatants were col- 12 quantities are reflected by the different band intensity of the
lected 48 hr later and IL-4 (top) and IFNg (bottom) were measured cDNA (position marked by an arrow) versus the competitor band.
by enzyme-linked immunosorbent assay. The means 6 SEM of data
from 3±4 mice per each group are shown. Results are representative
of three comparable experiments.
CD40-deficient mice mount an extremely polarized Th2
response to L. major, even compared with BALB/c mice,
suggesting that the defective Th1 response may be oneWe prepared CD40 expressing macrophages from
C57BL/6 mice that had been injected with proteose pep- of the causes of the failure of CD40-deficient mice to
resolve the infection. The CD40±CD40L system thus ap-tone. Macrophages were in vitro infected with L. major
and then stimulated with lipopolysaccharide (LPS) or pears to play a decisive role inemergence of Th1 effector
cells in some immune responses. This is underscoredanti-CD40 antibody in the presence of IFNg. The growth
of parasites was then quantitated by labeling with triti- by the observation that lymph node cells of the infected
mutant mice expressed significantly lower levels of IL-12ated thymidine after lysis of macrophages. As shown in
Figure 4a, both anti-CD40 and LPScould induce a strong mRNA in response to antigenic stimulation. IL-12 is
known to be a strong promoter of Th1 generation (Man-leishmanicidal activity in macrophages in the presence
of IFNg. The effect of CD40 ligation on leishmanicidal etti et al., 1993, 1994; Hsieh et al., 1993; Wu et al., 1993;
Seder et al., 1993). Chronic treatment with IL-12 canactivity was reproduced when peritoneal resident mac-
rophages were stimulated with CD40L expressing prevent susceptible BALB/c mice from the progression
of leishmaniasis by converting a Th2 response to a Th1transfectants. The leishmanicidal activity was also con-
firmed by counting of intracellular parasites (data not response, although delayed treatment is not efficient
(Heinzel et al., 1993; Sypek et al., 1993). Our result sug-shown). The results suggest that physical interaction of
macrophages and T cells via CD40 and CD40L may be gests that activation of macrophages through CD40 may
be required for IL-12 production in L. major-infectedrequired for induction of a leishmanicidal activity.
mice. This is also in accordance with a recent report
that activated T cells can induce IL-12 production byDiscussion
human monocytes via the CD40±CD40L interaction (Shu
et al., 1995).We show that the CD40±CD40L interaction is essential
for the cell-mediated immune responses to L. major. At present, we do not know whether a defect of IL-12
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infected CD40-deficient mice, which may partly contrib-
ute to polarized induction of Th2 responses. Alterna-
tively, an impairment of CD40±CD40L interaction may
directly affect the development of functional effector T
cells against L. major. Recently, it has been reported that
CD40±CD40L interaction is required for in vivopriming of
T cells and the development of helper T cell function
(Grewal et al., 1995; van Essen et al., 1995). Particularly,
van Essen et al. (1995) have shown that CD40L trans-
duced costimulation is required for maturation of func-
tional helper T cells. Therefore, a lack of signal through
CD40L may also be responsible for the failure of devel-
opment of protective T cells.
CD40 stimulation can activate macrophages to a
leishmanicidal state in vitro in the presence of IFNg. It
has been shown previously that LPS can induce a strong
leishmanicidal activity in macrophages in the presence
of IFNg. Our results suggest that the physical interaction
with activated T cells expressing CD40L may contribute
to the activation of macrophages to kill intracellular par-
asites in vivo. Nitric oxide is known to be an intracellular
effector molecule in L. major killing (Liew et al., 1990;
Wei et al., 1995). In fact, CD40 stimulation can induce
nitric oxide production in macrophages (Tian et al.,
1995). We also observed nitric oxide production in
CD40-stimulated macrophages during parasite killing
(data not shown).
The CD40-deficient mice develop less severe cutane-
ous lesions compared with the other susceptible mice,
BALB/c, although a large number of parasites could be
recovered from spleens as well as draining lymph nodes
of the infected mutant mice. A similar disease progres-
sion has been observed inL. major-infected severe com-
bined immunodeficiency mice, which display delayed
onset of local lesions but rapidly develop systemic leish-
maniasis (Holaday et al., 1991; Varkila et al., 1993). A
transfer of L. major-specific Th2 clone accelerates the
development of local cutaneous lesions of infected scid
mice (Varkila et al., 1993). In this context, it is interesting
that infected CD40-deficient mice display the milder lo-
Figure 4. CD40 Ligation Can Activate Macrophages to a Leishmani-
cal lesions even though they mount a Th2 response.cidal State
This implies that activation of macrophages by Th2 cells(a) Proteose peptone induced macrophage monolayers were in-
via the CD40±CD40L interaction may contribute to exac-fected with L. major promastigotes and then stimulated with anti-
erbation of local lesions by inducing macrophage-de-CD40 antibody or LPS in the presence or absence of IFNg. After 3
days culture with stimulants, parasites were recovered and pulsed rived inflammatory cytokines in infected susceptible
with [3H]thymidine. mice such as BALB/c.
(b) Resident macrophages were infected and stimulated with fixed In summary, CD40 may play an important role in two
CD40L-expressing CHO cells or fixed CHO cells in the presence of
distinct phases of the cell-mediated immune responseIFNg and survived parasites were measured. The values shown are
to L. major infection through macrophage activation;means 6 SEM of triplicate cultures. Results represent one of three
generation of a Th1 response and inductionof leishmani-comparable experiments.
cidal activity. Our results provide not only direct evi-
dence for the involvement of CD40 in cell-mediated im-
production is the only cause for the failure to generate mune responses butalso a new insight into host defense
Th1 response. It has been reported that B7-2 provides mechanisms against intracellular parasite infection.
signals for preferential induction of IL-4-secreting Th2
cells (Kuchroo et al., 1995; Freeman et al., 1995). B7-2
is constitutively expressed on professional antigen- Experimental Procedures
presenting cells such as macrophages and dendritic
cells, while B7-1 is inducible on those cells through
MiceCD40 ligation (Azuma et al., 1993; Freedman et al., 1991;
CD40-deficient mice were produced and maintained as described
Hart et al., 1993; Caux et al., 1994; Larsen et al., 1994). (Kawabe et al., 1994). (C57BL/6 3 129)F2 CD40-deficient mice (8±15
Thus, there is also a possibility that B7-1 may not be weeks old), their wild-type littermates, BALB/c mice, and C57BL/6
mice (SLC, Shizuoka, Japan) were used for the experiments.sufficiently induced on antigen-presenting cells of the
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Parasites and Infection measured by a liquid scintillation counter (1205 Betaplate, Wallac).
Murine CD40L-expressing CHO cells were provided by H. YagitaL. major (MHOM/SU/73/5ASKH) is a gift from Dr. K. Nagakura at
Tokai University. They were cultured as promastigotes as described (Juntendo University) and fixed with paraformaldehyde just before
usage.elsewhere (World Health Organization, 1990). Promastigotes were
harvested from stationary phase cultures and washed in phosphate-
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